Skip to main content

Security report for bms.com

Bristol Myers Squibb · Healthcare · United States

High risk. 6 critical or high findings in GDPR outside view and SSL/TLS.

Security score

45/100

Risk levelHigh

0–100, higher is better. How it is calculated

Bristol Myers Squibb is a globally recognized biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines for serious diseases. The website serves multiple audiences including patients, caregivers, healthcare providers, researchers, investors, and business partners, offering comprehensive resources and information. The business model focuses on pharmaceutical research, clinical trials, patient support, and strategic partnerships, positioning the company as a leader in the healthcare sector. Technically, the website is built on a robust infrastructure leveraging Adobe Experience Manager CMS, Apache server, and content delivery via Amazon CloudFront and Imperva. It employs modern analytics and marketing tools such as Adobe DTM, Microsoft Clarity, and Qualtrics, indicating a mature digital presence. The site is well-optimized for mobile and accessibility, with strong SEO practices and structured data implementation. From a security perspective, while the site implements several important security headers and cookie consent mechanisms, it suffers from a critical SSL certificate issue rendering HTTPS insecure. No modern TLS protocols are enabled, and advanced SSL features like OCSP stapling and session resumption are missing. These vulnerabilities pose risks to user data confidentiality and trust. Overall, the website is professional, content-rich, and trustworthy, but the SSL configuration significantly impacts its security posture. Strategic remediation of SSL and TLS issues is essential to enhance user trust and comply with best security practices.

Scanned

This is an earlier scan of bms.com. View the latest report

NIS2 and GDPR posture

GDPR outside view
0/ 100 · Critical
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

6 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • Critical

      No HTTPS encryption

      GDPR requires appropriate security measures for personal data

      What to do: Implement SSL/TLS certificate for HTTPS

    • High

      No Privacy Policy found

      GDPR requires a clear and accessible privacy policy

      What to do: Add a comprehensive privacy policy page and link to it prominently

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • Critical

      No HTTPS Encryption

      Website does not use HTTPS encryption, making all data transmission vulnerable to interception

      What to do: Implement SSL/TLS certificate and redirect all HTTP traffic to HTTPS

Need hands-on remediation? Email guard@offseq.com

Keep watching bms.com

This scan found 14 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
0
Security headers
70
Email security
50
DNS health
50
Network security
100
GDPR outside view
0
Average
45

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Breach exposure

Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.

Dark web exposure

Add-on

Leaked records that mention bms.com, from OffSeq Breach.

Total records
16,389
Employees
17
Customers
2,067
Third parties
14,305
Weak passwords
4%

Latest record dated 2025-12-10 · 120 subdomains affected

See the 10 newest leaked credentials

A one-off add-on to this report that lists the most recent identifier and password pairs OffSeq Breach holds for bms.com.

Select it in the checkout above.

Masked preview

  • –advath.bms.com2025-12-10
  • –smusxath.bms.com2025-11-13
  • –advath.bms.com2025-09-16
  • –smusxath.bms.com2025-09-02
  • –smusfedath.bms.com2025-08-19

Breach keeps ingesting new leaks, so these numbers can grow between scans.

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Bristol Myers Squibb operates in the healthcare sector with a focus on biopharmaceuticals. The company targets a broad audience including patients, healthcare professionals, researchers, and investors. Its competitive advantage lies in innovative drug development and a strong global presence. The website reflects a mature business model with diversified revenue streams from medicines, clinical trials, and partnerships. The presence of multiple official domains and social media channels indicates a well-established partnership ecosystem. Growth indicators include active clinical trial information and ESG reporting. The company maintains a strong brand with consistent messaging and comprehensive resources.

Security posture

The website demonstrates moderate security maturity with implementation of key security headers such as X-Content-Type-Options, X-Frame-Options, Content Security Policy, and HSTS. Cookies are set with HttpOnly and Secure flags. However, the absence of a valid SSL certificate and lack of TLS protocol support are critical vulnerabilities that undermine the security posture. No evidence of incident response or security policy documentation was found. Privacy compliance is supported by cookie consent mechanisms and a comprehensive privacy policy. The site lacks vulnerability disclosure and data protection officer contact information, indicating room for improvement in security governance.

Recommendations

  1. Obtain and deploy a valid SSL certificate to enable secure HTTPS connections.
  2. Enable modern TLS protocols (TLS 1.2 and TLS 1.3) and disable deprecated protocols.
  3. Implement OCSP stapling and session resumption to improve SSL performance and security.
  4. Publish a clear security policy and vulnerability disclosure program to enhance transparency.
  5. Include data protection officer contact information to support GDPR compliance and user trust.

Contact details published on the site

Addresses
Legal name
Bristol-Myers Squibb Company
Technical notes

Notes

The website is hosted on Apache servers behind Amazon CloudFront CDN and protected by Imperva CDN/WAF. It uses Adobe Experience Manager CMS, with client libraries and scripts indicating a modern front-end stack including jQuery and Adobe DTM for tag management. Analytics are handled via Microsoft Clarity and Qualtrics for surveys. The site is mobile optimized and accessible, with good SEO practices including meta tags, Open Graph, Twitter cards, and JSON-LD structured data. Performance metrics were not provided but the use of CDNs suggests moderate to good performance. The main technical risk is the invalid SSL configuration which could impact user trust and SEO rankings.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Earlier scans of this domain

  1. 79/100Low27 findingsView report
Reviews of this site

Share your experience with bms.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review bms.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.